Pfizer Limited has announced the issuance of a certificate confirming compliance with SEBI’s Depositories and Participants Regulations for the quarter ended December 31, 2025. The certificate, dated January 7, 2026, was issued by KFin Technologies Limited, the Registrar & Share Transfer Agent of the company. This confirms adherence to regulatory standards regarding dematerialization of securities.
Regulatory Compliance Confirmed
Pfizer Limited has received a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for Q3 FY26. This announcement was made on January 9, 2026.
Details of the Certificate
The certificate, dated January 7, 2026, was issued by KFin Technologies Limited, the Registrar & Share Transfer Agent of Pfizer Limited. It confirms that all securities received for dematerialization during the quarter ended December 31, 2025, have been processed in accordance with the regulations.
Confirmation from KFin Technologies
KFin Technologies confirmed that securities received from depository participants for dematerialization during the quarter ended December 31, 2025, were confirmed or rejected to the depositories. They also confirmed that the security certificates received for dematerialisation have been mutilated and cancelled after verification.
Source: BSE
